Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$28.82 - $77.35 $12,738 - $34,188
-442 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$48.25 - $100.49 $3,088 - $6,431
-64 Reduced 12.65%
442 $29,000
Q4 2021

Feb 18, 2022

BUY
$88.71 - $120.43 $44,887 - $60,937
506 New
506 $51,000
Q3 2021

Nov 16, 2021

SELL
$98.77 - $132.17 $51,064 - $68,331
-517 Closed
0 $0
Q2 2021

Aug 17, 2021

BUY
$109.77 - $165.68 $3,732 - $5,633
34 Added 7.04%
517 $64,000
Q1 2021

Jun 08, 2021

BUY
$127.04 - $179.1 $61,360 - $86,505
483 New
483 $74,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.